Reddit Posts
Aligos Therapeutics (ALGS) - The next biotech 100x runner
Feetr Data Dump: WISA OMH LMFA ALGS MGOL GSIT PXMD
New weekly gainers - top 3 most hyped stocks on Twitter!
New weekly gainers - top 3 most hyped stocks on Twitter!
New weekly gainers - top 3 most hyped stocks on Twitter!
Mentions
I currently own approximately 5,000 shares. I anticipate a dilution with the upcoming interim results during the first half of the year. While I would appreciate some interest for the MASH, I don’t anticipate anything extraordinary in that regard. Furthermore, I strongly oppose the management’s decision to invest heavily in MASH alone, as later-stage trials for the MASH are extremely costly. The most favorable scenario for ALGS would be to attract the attention of major pharmaceutical companies with the CHB interim data. Positive data should help for reevaluation of the company’s market cap, resulting in favourable funding that would provide better leverage in future deal-making opportunities. GL!!
I concur; the MASH sector is highly competitive. I anticipate that novel pharmaceutical developments from Zealand/BI and Lilly will establish new benchmarks within the next one to two years. ALGS's primary asset is CHB.
Ah thanks mate! I was getting frustrated with 212's limitations. Signed up on IBKR right away. I'm definitely growth-oriented so ALGS looks like the perfect opportunity. Great breakdown btw. Appreciate the effort you put into this.
What's going on with ALGS
My Pennystock holding $UUU - few more days, I made more than 50% profit yesterday alone $CJET - few days $FBIO - few weeks or may be more let's see $NRXP - a month or two $CGTX - a year or more $PHRRF - a year or more : accumulating $ALGS - a year or more : accumulating
Sure thing: ALGS: > Aligos Therapeutics, Inc. (ALGS) is currently trading at $19, showing a strong upward momentum with the RSI indicating overbought conditions across multiple timeframes, suggesting potential for a pullback. The MACD histogram is positive, reinforcing bullish sentiment, while the stock's recent surge above its 10-day SMA of $15.81 and 20-day EMA of $13.90 highlights strong buying pressure. Despite the lack of recent news or significant market interest, the technical indicators suggest a continuation of the uptrend, albeit with caution due to overbought signals. Given the broader market's cautious optimism, ALGS may experience moderate volatility. For today's session, consider a LONG position with an entry around $18.50, targeting $21.00 as the first price target and $23.00 as the second, with a stop loss at $17.00. Confidence in reaching the first target is moderate due to current momentum, while the second target carries lower confidence given potential resistance and market uncertainties. Keep an eye on broader market movements and any emerging news that could impact sentiment. MBLY: > Mobileye Global Inc. (MBLY) is showing signs of short-term bullish momentum, supported by a positive MACD histogram and RSI levels above 60, indicating potential upward movement. The stock's current price of $16.90 is above its 10-day SMA of $16.33, suggesting recent strength, while the broader market sentiment is cautiously optimistic, with technology sectors showing resilience. Recent partnerships and speculation about growth prospects in the autonomous driving sector add to the positive sentiment, although competition remains a concern. Given the high short interest, a short squeeze could further propel the stock upwards. For today's trading session, consider a long position with an entry around $16.80, targeting $17.20 as the first price target and $17.50 as the second, with a stop loss at $16.40 to manage risk. Confidence in reaching the first target is moderate due to mixed market signals, but the second target carries lower confidence given potential resistance and broader market uncertainties. Keep an eye on upcoming announcements and market conditions for any shifts in sentiment. CLDI > Calidi Biotherapeutics, Inc. (CLDI) is currently trading at $2.40, showing a strong upward momentum following its recent public offering priced at $1.69 per share, which raised $7.5 million for operational and R&D purposes. The stock's technical indicators are bullish, with the 10-day SMA at $2.08 and the 8-day EMA at $2.18, suggesting continued upward pressure. The RSI values around 60 indicate moderate buying strength without being overbought, while the MACD histogram supports a positive trend. Despite the lack of significant market sentiment or news, the successful capital raise and potential for future growth could attract investor interest. Given the broader market's cautious optimism, CLDI may experience moderate volatility but with an upward bias. For today's session, consider a long position with an entry around $2.35, targeting $2.60 as the first price target and $2.75 as the second, with a stop loss at $2.20. Confidence in reaching the first target is moderate due to recent positive developments, while the second target carries lower confidence given potential market fluctuations. BIVI: > BioVie Inc. (BIVI) is currently trading at $3.51, showing a strong upward momentum with the 10-day SMA at $3.08 and the 8-day EMA at $3.22, indicating a bullish trend. The RSI values are high, suggesting the stock is overbought, but the MACD histogram remains positive, supporting continued upward movement. Recent trading volumes have been significant, surpassing the 65-day average, which could indicate sustained interest despite the lack of specific news catalysts. Broader market sentiment is cautiously optimistic, with SPY and QQQ showing resilience, which may support BIVI's upward trajectory. Given these factors, a long position is recommended with an entry around $3.50, targeting $3.75 as the first price target and $4.00 as the second, with a stop loss at $3.30 to manage downside risk. Confidence in reaching the first target is moderate due to current momentum, while the second target carries lower confidence given potential resistance and broader market uncertainties. Investors should remain vigilant for any sudden changes in market conditions or unexpected news that could impact BIVI's performance. NXL: > Nexalin Technology, Inc. (NXL) is currently trading at $3.97 with a market cap of approximately $49.9 million and no significant news driving its movement. The stock has shown a strong upward trend recently, with the 10-day SMA at $3.73 and the 20-day EMA at $3.12, indicating bullish momentum. The RSI values are above 60, suggesting the stock is not yet overbought but is approaching that territory. The MACD histogram is positive, reinforcing the bullish sentiment. Given the broader market's cautious optimism and NXL's technical indicators, a long position could be considered. For today's session, an entry price around $3.95 is advisable, with a first target of $4.10 and a second target of $4.25, while setting a stop loss at $3.80 to manage risk. Confidence in reaching the first target is moderate due to the lack of volume and market interest, while the second target carries lower confidence unless new catalysts emerge.
BIVI CLDI ALGS take your pick
They sure will be if done right. They can fill some stadiums with a crowd... ALGS had one of its biggest turnouts recently. If NFL AFL NFC MLB etc... etc... can do it so can esports. Just before covid ALGS planned 12 Lans 1 a month... Just need the games and format to be right. Not to mention some announcers that know amd play video games.
I like having a flutter on a meme stock, it's good fun and can be lucrative, but it's a small part of my portfolio. Its better to invest in good companies with great growth prospects. I balance these with energy and mining dividend stocks, and a few REITS. from yahoo finance SPCE increase in revenue, but also a big jump in cost of revenue, try and find out why AIU Increase in revenue in 2023, this would be on my watchlist if it wasn't Chinese ALGS a pharma company, these are hard to judge, some revenue with huge operating expenses, no idea about this company, I have VNRX as my only pharma stock, because I expect them to become profitable in about a year, they have developed an early cancer test TNXP a pharma company with no revenue, I avoid such companies ARBKF a blockchain company, barely breaking even, they look they have a nerdy leadership, I am not into blockchain PLNH this might grow, hard for me to know, an American resident/citizen could have more insight into the local cannabis industry. A decision on selling or keeping? not financial advice but I would sell the pharma stocks , I might wait until they have posted some positive data.
TSM got 17/20 in ALGS. Fuck my calls I held
I'm long $ALGS (Aligos Therapuetics) $2.50 Calls with 3/15 expiry; They are reporting on a new metabolic drug trial at 4:00pm EST today (3/7) and earnings are on uesday (3/12). Stock trades at $1.00, has traded as high as $30. Could be a good pop to the upside based on the independent doctor assessments of the earlier phases.
ALGS. A director bought 6 million worth of shares at .76 cents. It has been trading well below that for a while, it started a run yesterday.
Looks like an exciting company with a big insider purchase. I like biotech this 1st quarter of 2024. ALGS has two analysts with an average target price of $7.00. [https://www.tipranks.com/stocks/algs/forecast](https://www.tipranks.com/stocks/algs/forecast) Just got to know that they will have to raise capital in the next few months. Good data, though.
As a doctor, i don't think this is such a massive breakthrough. I couldn't find many details though. In my opinion, the only case sceneario where this is rather huge, is if this Hep B treatment can cure woman with chronic Hep B infection that plan on getting pregnant, and even then, there's already a treatment for the newborn that decreases the chance of vertical infection a lot. ITRM on the other hand, shows promise with it's antibiotics. See, most sever UTI's are treated with EV antibiotics. These guys are trying to come up with Sulopenem, an oral alternative which could mean a huge change in the patient load we get at hospitals. I see an old lady with UTI every other week, is that common. If this gets aproved, i wouldn't have to send them to the emergency department. That said, i may put some $ in **ALGS** just to display that i may be wrong lol.
> We don’t watch any sports from a first person perspective. This is not really true. Twitch has a "command center" feature that lets the tournament organizer stream player perspectives. It can also hook into streamed audio from the players. It's used in ALGS tournaments for apex legends at least.
Hey all! Hope you had a great weekend! I'm still recovering so I'll answer any queries in a little bit. Premarket this morning has been mostly boring but with a few really interesting stocks rocketing at times. WISA is a stock that shows up every few days and has done since probably the middle of last year. I don't think I've ever seen it have such a good morning. There does seem to be a really well defined ceiling that it has been unable to break through and you should keep your eye on that. If it manages to overcome the resistance then it's very possible it could run quite far. If. OMH is wild right now. Opened about $18. Broke $28 twice so far. It's a scary chart because you have to look at it from the perspective of "am I able to trade that" and it's something that you're going to need to be watching for CONSTANTLY. That's assuming it can repeat this kind of movement. LMFA came in really late and is mostly trending on what can only be described as a hilariously good earnings report. 1110% icnrease of 2022. I mean. Sure. Okay. Yeah. Of course with it being a smaller cap stock this does mean that it's going to fluctuate a lot. My immediate concern with this is that it runs too high between now and open, and it really restricts how much profit one can hope for today. Or, even worse, it causes people to sell their shares and we see a huge tumble down. Do be careful. GSIT was amazing on Friday and somehow even better after hours. This morning has been, for lack of a better term, a shit show. $7 down to under $5. Why is it here, you may be asking? Well, if a reversal does happen, it could bring substantial profits. Though, considering that this was about $1.70 on Thursday, the potential downside is huge. MGOL started off well and trended at around $2 for a few hours but the selling pressure was too much and it pulled back as far as $1.75-ish. I think that if it can break through, we may see it run as high as $2.20-$2.40 (maybe higher?) but`, again, that's a "if". Currently trending down. You will want to be careful of the first few minutes. Don't try and catch a falling knife. ALGS is largely the same story as GSIT but without the impressive movement on Friday. I think that this is potentially one to scalp vs try and hit one big trade. PXMD. I mean, you've seen it here all weekend. Lots of momentum but so far that hasn't converted into a good premarket. It's possible that it'll change when the market does open but this needs volume and it's 50/50 whether it gets it. The chart isn't awful though, that's just a fact. Outside of those, MIND is late to the party but are bringing A LOT of energy. I'd be watching them if I were you. Small market cap, insane movement, break out day. What's not to love? (the clear and present danger, that's what) Also, we're starting to use ChatGPT for stock analysis. One of the big issues that we encounter is that're not in a position where we can legally provide very actionable advice. We are looking to overcome that but in the meantime, we're throwing stock market data, technical analysis, and our own proprietary data at ChatGPT and it's looking really promising. It's still a work in progress, of course, but I'm pretty optimistic about it. Can see an example here: https://i.imgur.com/wgR0W9Z.png
Anyone play Apex? ALGS was litty
thoughts on ALGS short squeeze potential?
I am a bot. You submitted a picture of a banned ticker, ALGS. The market cap of ALGS is **53794610** This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1 billion-ish market cap and not related to crypto/pennies/OTC.
What do y’all think of $ALGS you think it’s worth holding onto?
Y’all think $ALGS is going anywhere?
**On $ALGS - My Recap on Aligos Therapeutics:** **Material on their website has been updated, including focusing in on the JP Morgan presentation. My take is that they still have the core strategy and focus in place regarding CHB. The premature ending of a phase 1 from last week had a Hep. focus so does not present a negative on their CHB strategy. With the CHB and NASH focus (NASH with Merck), this remains a vibrant biotech to keep an eye on. An FIP (first in patient) notation seems to be marked for sometime mid to end of January. The price is battered down needlessly due to excessive shorting but will recover to at least a mid point between 4 and 17. Full disclosure, I bought in last Thursday for a tiny round, and may add depending on if it maintains a lower price point. All this is my opinion only.**
My plays for today $LWAY and $ALGS just scrapping by today
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: ALGS. Message /u/zjz if they're above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
You pay for water to people who actually bought my own wedding ring. Some people have it. Both need to be realistic A cop can’t know who’s supposed to be bugged/unbalanced resource generations, and people could provide better answers, if you for example were a bad person. I learned my lesson in the beginning \[...\]これまで慣れ親しんだ気候**と**近い環境への移住をおすすめしております。 but what would be super scary in ALGS Champs...